Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Anus Neoplasms

fluorodeoxyglucose f18 has been researched along with Anus Neoplasms in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (17.46)29.6817
2010's37 (58.73)24.3611
2020's15 (23.81)2.80

Authors

AuthorsStudies
Adusumilli, P; Casanova, N; Cooper, R; Elsayed, N; Gilbert, A; Samuel, R; Scarsbrook, AF; Theophanous, S; Tolan, DJ1
Foroudi, F; Joon, DL; Khoo, V; Knight, K; Lau, E; Schneider, M; Sim, J; Smith, D1
Bates, DDB; Ernst, R; Gangai, N; Golia Pernicka, JS; Gollub, MJ; Hope, TA; Horvat, N; Rauch, GM; Sheedy, SP1
Fraum, TJ; Hope, TA; Ince, S; Jayaprakasam, VS; Nepal, P; Paspulati, RM; Suman, G1
Arcadipane, F; Balestra, G; Dinapoli, N; Fato, M; Fiandra, C; Franco, P; Gallio, E; Ricardi, U; Rosati, S; Scaffidi Gennarino, D; Silvetti, P; Zara, S1
Bell, J; Mac Curtain, BM; Ng, ZQ; O'Mahony, A; Qian, W; Temperly, HC1
Carré, A; Chargari, C; Classe, M; Deutsch, E; Genestie, C; Guckenberger, M; Guren, MG; La Greca Saint-Esteven, A; Lemanski, C; Malinen, E; McDermott, G; McKenna, J; Niyoteka, S; Robert, C; Rouhi, R; Scarsbrook, A; Seban, RD; Sun, R; Tanadini-Lang, S1
Acosta Roa, AM; Guren, MG; Hernes, E; Malinen, E; Rekstad, BL; Rusten, E; Skingen, VE; Undseth, C1
Appelt, AL; Brown, PJ; Currie, S; Frood, R; Gilbert, A; Scarsbrook, A; Sebag-Montefiore, D; Zhong, J1
Chu, KY; Cooke, R; Hawkins, M; Jacobs, C; Muirhead, R; Ng, S; Robinson, M; Strauss, V; Van den Heuvel, F; Virdee, P1
Barone, R; Gambacorta, MA; Giordano, A; Leccisotti, L; Manfrida, S; Masiello, V; Privitera, V; Ripani, D; Rufini, V; Tagliaferri, L; Valentini, V1
Li, W; Li, X; Xia, Z1
Appelt, A; Brown, P; Scarsbrook, A; Sebag-Montefiore, D1
Kiyota, T; Matsumoto, S; Otsuka, K; Sena, Y; Silman, C1
Bagni, O; Filippi, L; Fontana, A; Rossi, L; Spinelli, GP1
Buchwald, P; Frennered, A; Johnsson, A; Nilsson, MP; Sartor, H; Scherman, J; Trägårdh, E; Zackrisson, S1
Arcadipane, F; Fiandra, C; Franco, P; Giglioli, FR; Ragona, R; Ricardi, U; Trino, E1
Cheng, Z; Kuang, D; Song, S; Zhu, X; Zou, S1
Albertsson, P; Alverbratt, C; Björkander, E; Hallqvist, A; Liljegren, A; Palm, S; Samuelsson, O; Strandell, A1
Feingold, D; Gaertner, WB; Glasgow, SC; Herzig, DO; Steele, SR; Stewart, DB1
Cui, Y; Czito, BG; Das, S; Eng, JS; Faught, AM; Higgins, K; Hong, JC; Palta, M; Patel, BN; Rushing, CN; Willett, CG; Yin, FF1
Ankrah, AO; Kaoma, CA; Lawal, IO; Maes, A; Mokgoro, NP; Mokoala, KMG; Popoola, GO; Sathekge, MM; Van de Wiele, C1
Aznar, MC; Chu, KY; Cooke, R; Hawkins, MA; Jacobs, C; Muirhead, R; Ng, SM; Sabbagh, A; Strauss, VY; Virdee, PS1
Dabbagh, VR; Harsini, S; Qodsi Rad, MA; Sadeghi, R; Treglia, G1
Guren, MG; Hernes, E; Klotz, D; Malinen, E; Rekstad, BL; Rusten, E; Undseth, C1
Doll, C; Duimering, A; Fairchild, A; Ghosh, S; Joseph, K; MacEwan, R; Mulder, K; Nijjar, T; Nijjar, Y; Riauka, T; Schiller, D; Severin, D; Tankel, K; Usmani, N; Warkentin, H; Wong, C1
Canevari, C; De Nardi, P; Guarneri, G; Passoni, P; Rosati, R; Slim, N; Tamburini, A1
Capp, A; Gallagher, S; Holder, C; Hruby, G; Jones, MP; Kumar, M; Martin, J; Metser, U; Oldmeadow, C; Rutherford, N; Sridharan, S1
Annunziata, S; Ayati, N; Caldarella, C; Giovanella, L; Sadeghi, R; Treglia, G1
Agarwal, A; Kachnic, LA; Marcus, C; Nene, P; Subramaniam, RM; Xiao, J1
Hruby, G; Jones, M; Martin, J; Rutherford, N; Solomon, M1
Brambilla, M; Cena, T; Deantonio, L; Krengli, M; Milia, ME; Perotti, C; Sacchetti, G; Turri, L1
Allen, JN; Blaszkowsky, LS; Drapek, LC; Hong, TS; Jee, KW; Lee, LK; Murphy, JE; Niemierko, A; Rose, BS; Wang, Y; Wo, JY1
Burkill, GJ; Dizdarevic, S; Gilbert, DC; Jones, JR; McKinna, F; Teagle, AR1
Braun, M; Falch, C; Kirschniak, A; Klumpp, B; Koenigsrainer, A; Mueller, S1
Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH1
Alberini, JL; Cacheux, W; Fayard, J; Gauthé, M; Lièvre, A; Richard-Molard, M1
Drummond, E; Fay, M; Heriot, AG; Hicks, RJ; Hogg, A; Leong, T; MacKay, J; Milner, A; Ng, M; Ngan, SY; Winton, Ed1
Dinter, DJ; Haberkorn, U; Hermann, B; Mai, SK; Welzel, G; Wenz, F1
Bellò, M; Beltramo, G; Cassoni, P; Castellano, I; Contu, V; Mistrangelo, M; Morino, M; Munoz, F; Mussa, A; Pelosi, E; Racca, P; Ricardi, U1
Betler, J; Day, E; Kirichenko, A; Miften, M; Mohammadi, S; Parda, D; Reitz, B1
Blackman, G; Bomanji, J; Boulos, PB; Ell, PJ; Engledow, AH; Groves, A; Skipworth, JR; Warren, SJ1
Bassi, MC; Brambilla, M; Cannillo, B; Deantonio, L; Inglese, E; Krengli, M; Milia, ME; Mones, E; Sacchetti, G; Turri, L1
Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA1
Adam, G; Bannas, P; Derlin, T; Frenzel, T; Klutmann, S; Mester, J; Weber, C1
Bauer, P; de Parades, V; Huchet, V; Kerrou, K; Montravers, F; Talbot, JN; Touboul, E; Vercellino, L1
Lindskog, DM; Nikkhou, K; Talusan, P1
Day, FL; Heriot, A; Hicks, RJ; Hogg, A; Leong, T; Link, E; Lynch, C; Michael, M; Moodie, K; Ngan, S; Winton, Ed1
Fox, BM; Wells, IT1
Bhuva, NJ; Glynne-Jones, R; Harrison, MK; Sonoda, L; Wong, WL1
Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A1
Bydder, GM; Bydder, M; Cornell, M; Einck, J; Fanta, P; Hoh, CK; Lawson, JD; Liang, Y; Mell, LK; Mundt, AJ; Rose, BS; Saenz, C; Yashar, CM1
Carrington, BM; Kochhar, R; Plumb, AA; Saunders, M1
Kim, BS1
Krajewski, KM; Ramaiya, N; Saboo, SS; Shinagare, AB; Zukotynski, K1
Abbey, E; Birnbaum, EH; Cotter, SE; Dehdashti, F; Dietz, DW; Fleshman, JW; Grigsby, PW; Hunt, SR; Kodner, IJ; Lowney, JK; Malyapa, RS; Mutch, MG; Myerson, RJ; Siegel, BA; Tan, B; Wang, X1
Gambhir, SS; Niederkohr, RD1
Nguyen, BD; Ram, PC; Roarke, MC1
Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N1
Anderson, C; Esiashvili, N; Esteves, F; Fowler, Z; Fox, T; Ghavidel, S; Godette, K; Koshy, M; Landry, J; Staley, C1
Chiou, JF; Hsu, CH; Lin, SE; Tai, CJ; Wu, CH1
Dehdashti, F; Fleshman, JW; Grigsby, PW; Myerson, RJ; Schwarz, JK; Siegel, BA1
Chao, M; Feigen, M; Joon, DL; Joon, ML; Kai, C; Khoo, V; Nguyen, BT; Quong, G; Rykers, K; Scott, A; See, A; Wada, M; Zupan, E1

Reviews

11 review(s) available for fluorodeoxyglucose f18 and Anus Neoplasms

ArticleYear
Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.
    Abdominal radiology (New York), 2023, Volume: 48, Issue:9

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Expert Testimony; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology

2023
PET/MRI in colorectal and anal cancers: an update.
    Abdominal radiology (New York), 2023, Volume: 48, Issue:12

    Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals

2023
Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis.
    Journal of medical imaging and radiation oncology, 2023, Volume: 67, Issue:6

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies

2023
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis.
    Critical reviews in oncology/hematology, 2018, Volume: 126

    Topics: Anus Neoplasms; Chemoradiotherapy; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quality of Life; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted

2018
Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis.
    Contrast media & molecular imaging, 2018, Volume: 2018

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Burden

2018
Diagnostic performance of positron emission tomography/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis.
    TheScientificWorldJournal, 2014, Volume: 2014

    Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed

2014
FDG PET/CT in the management of colorectal and anal cancers.
    AJR. American journal of roentgenology, 2014, Volume: 203, Issue:5

    Topics: Adult; Aged; Anus Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed

2014
The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
    Annals of surgical oncology, 2015, Volume: 22, Issue:11

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome

2015
Imaging of anal carcinoma.
    AJR. American journal of roentgenology, 2012, Volume: 199, Issue:3

    Topics: Anus Neoplasms; Chemoradiotherapy; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed

2012
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
    Abdominal imaging, 2013, Volume: 38, Issue:4

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome

2013
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
    Bulletin du cancer, 2007, Volume: 94, Issue:2

    Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms

2007

Trials

4 trial(s) available for fluorodeoxyglucose f18 and Anus Neoplasms

ArticleYear
Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence.
    International journal of radiation oncology, biology, physics, 2018, 11-15, Volume: 102, Issue:4

    Topics: Anus Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome

2018
Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2009, Volume: 185, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Body Burden; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiation Protection; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome

2009
The role of ¹⁸fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2011, Volume: 13, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed

2011
FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.
    Radiation oncology (London, England), 2010, Feb-06, Volume: 5

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed

2010

Other Studies

48 other study(ies) available for fluorodeoxyglucose f18 and Anus Neoplasms

ArticleYear
Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
    European radiology, 2022, Volume: 32, Issue:8

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Epithelial Cells; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies

2022
A pilot study investigating the role of
    Journal of medical radiation sciences, 2022, Volume: 69, Issue:4

    Topics: Anus Neoplasms; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Pilot Projects; Radiopharmaceuticals

2022
Active bone marrow segmentation based on computed tomography imaging in anal cancer patients: A machine-learning-based proof of concept.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2023, Volume: 113

    Topics: Anus Neoplasms; Bone Marrow; Fluorodeoxyglucose F18; Humans; Machine Learning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2023
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:13

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human Papillomavirus Viruses; Humans; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms

2023
Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2023, Volume: 114

    Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tumor Burden

2023
Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:13

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies

2019
Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 143

    Topics: Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Pelvis; Radiotherapy, Intensity-Modulated

2020
The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.
    Annals of nuclear medicine, 2020, Volume: 34, Issue:1

    Topics: Anus Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies

2020
Radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:12

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2020
In reply to letter to the editor: radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:12

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2020
Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
    Annals of nuclear medicine, 2020, Volume: 34, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anal Canal; Anus Neoplasms; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies

2020
Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
    Nuclear medicine communications, 2020, Volume: 41, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Tumor Burden

2020
Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
    BMC cancer, 2021, Apr-22, Volume: 21, Issue:1

    Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography

2021
Incorporating
    BMC cancer, 2017, Nov-02, Volume: 17, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Bones; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results

2017
Anal Malignant Melanoma Manifesting Hepatic Metastases Shown on FDG PET/CT.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:5

    Topics: Adult; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2018
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018).
    Diseases of the colon and rectum, 2018, Volume: 61, Issue:7

    Topics: Ablation Techniques; Administration, Topical; Aftercare; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Colorectal Surgery; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Papanicolaou Test; Papillomavirus Infections; Papillomavirus Vaccines; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Societies, Medical; Survival Rate

2018
Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
    Nuklearmedizin. Nuclear medicine, 2018, Volume: 57, Issue:5

    Topics: Adult; Age Factors; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV; HIV Infections; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate

2018
Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2019, Volume: 31, Issue:2

    Topics: Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies

2019
Anal cancer chemoradiotherapy outcome prediction using
    The British journal of radiology, 2019, Volume: 92, Issue:1097

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Papillomaviridae; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Burden

2019
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019, Volume: 136

    Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden

2019
Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2019, Volume: 21, Issue:9

    Topics: Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy

2019
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
    Radiation oncology (London, England), 2019, Aug-06, Volume: 14, Issue:1

    Topics: Adult; Aged; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated

2019
Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.
    La Radiologia medica, 2016, Volume: 121, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Biopsy; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome

2016
Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
    International journal of radiation oncology, biology, physics, 2016, Mar-15, Volume: 94, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cohort Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Linear Models; Male; Middle Aged; Mitomycin; Neutropenia; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors

2016
Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.
    Nuclear medicine communications, 2016, Volume: 37, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies

2016
Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT.
    World journal of surgical oncology, 2016, Jul-15, Volume: 14, Issue:1

    Topics: Aged; Anal Canal; Anus Neoplasms; Colon, Sigmoid; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Retrospective Studies; Treatment Outcome

2016
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
    European journal of radiology, 2016, Volume: 85, Issue:8

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden

2016
Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; France; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden

2017
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.
    British journal of cancer, 2009, Mar-10, Volume: 100, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity

2009
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
    International journal of radiation oncology, biology, physics, 2010, May-01, Volume: 77, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy

2010
A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients.
    Medical physics, 2009, Volume: 36, Issue:10

    Topics: Algorithms; Anus Neoplasms; Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity

2009
Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2010, Volume: 95, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals

2010
Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    International journal of radiation oncology, biology, physics, 2011, Oct-01, Volume: 81, Issue:2

    Topics: Adult; Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed

2011
Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma.
    International journal of colorectal disease, 2011, Volume: 26, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed

2011
False-positive positron emission tomography in patients with history of malignancy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jul-01, Volume: 29, Issue:19

    Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed

2011
FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
    British journal of cancer, 2011, Aug-09, Volume: 105, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Confounding Factors, Epidemiologic; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome

2011
PET/CT in anal cancer - is it worth doing?
    Clinical radiology, 2012, Volume: 67, Issue:6

    Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2012
To PET or not to PET? That is the question. Staging in anal cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:8

    Topics: Anus Neoplasms; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2012
Role of positron emission tomography-computed tomography in the management of anal cancer.
    International journal of radiation oncology, biology, physics, 2012, Sep-01, Volume: 84, Issue:1

    Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed

2012
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
    International journal of radiation oncology, biology, physics, 2013, Feb-01, Volume: 85, Issue:2

    Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cisplatin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Multimodal Imaging; Organ Sparing Treatments; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms

2013
The 18F-FDG PET/CT finding of a condyloma acuminata mimicking primary anorectal carcinoma in an HIV-infected patient.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:10

    Topics: Adult; Anus Neoplasms; Condylomata Acuminata; Diagnosis, Differential; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed

2013
FDG-PET/CT in the evaluation of anal carcinoma.
    International journal of radiation oncology, biology, physics, 2006, Jul-01, Volume: 65, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Inguinal Canal; Lymph Nodes; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed

2006
F-18 FDG PET/CT imaging of extramammary Paget disease of the perianal region.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:9

    Topics: Anus Neoplasms; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2006
F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
    Clinical nuclear medicine, 2007, Volume: 32, Issue:3

    Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2007
PET-CT fusion in radiation management of patients with anorectal tumors.
    International journal of radiation oncology, biology, physics, 2007, Sep-01, Volume: 69, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed; Tumor Burden

2007
FDG uptake in a rectal malignant melanoma.
    Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:7

    Topics: Adult; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals

2007
Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
    International journal of radiation oncology, biology, physics, 2008, May-01, Volume: 71, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed

2008
Assessing the impact of FDG-PET in the management of anal cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2008, Volume: 87, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals

2008